Following up tumor-specific regulatory T cells in cancer patients. - Wikidata - awgldk - TriplyDB

Following up tumor-specific regulatory T cells in cancer patients.

Following up tumor-specific regulatory T cells in cancer patients.

http://www.wikidata.org/entity/Q37195258

about

Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1 Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subset Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients.Consensus guidelines for the detection of immunogenic cell death.Trial Watch: Radioimmunotherapy for oncological indications.Trial Watch: Chemotherapy with immunogenic cell death inducers.

P2860

Q26741263-B1820E2D-CD6F-47A7-B2C6-0B7ED74BEDB1 Q33658400-13166DA1-F7E5-4096-9059-9C47D866059A Q36060343-D7418915-FB88-498D-BB5B-F86430121552 Q37743471-7A7052FA-D701-49EC-BAD1-611F3045A6DB Q42205109-D0A15BAE-ABE0-47E2-B72A-B68A33D77B3D Q42553556-0CCFB011-FEFD-42FC-97A4-246A7B47BC49 Q43104064-6CEABE70-1DB7-40A7-B31F-68667C6C6E5D Q55260834-4B17CAC4-310E-4003-87ED-C39A860DF8BA

P2860

Following up tumor-specific regulatory T cells in cancer patients.

http://www.wikidata.org/entity/Q37195258

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Following up tumor-specific regulatory T cells in cancer patients.

@en

Following up tumor-specific regulatory T cells in cancer patients.

@nl

type

label

Following up tumor-specific regulatory T cells in cancer patients.

@en

Following up tumor-specific regulatory T cells in cancer patients.

@nl

prefLabel

Following up tumor-specific regulatory T cells in cancer patients.

@en

Following up tumor-specific regulatory T cells in cancer patients.

@nl

P1433

Q37195258-6BC8A605-66A6-414D-983E-78BEF6382DE4

P1476

Q37195258-B04E227E-A52E-465C-B6A2-D8C2DAA1B65C

P2093

Q37195258-6D095664-BA10-48E0-8A12-E172D7F607A4

Q37195258-B54EB886-D472-4F9E-8A1A-F1CBED1E23B9

P2860

Q37195258-23E144B6-3DBF-4FC1-9491-B16A90F5C9CF

Q37195258-251A84A3-5494-477B-ADCF-39C8AA340FB2

Q37195258-36311457-E1F7-4AC2-9F8C-B8F2ACF53B12

Q37195258-4DB44268-ED54-4864-BBBC-3CCE2C320934

Q37195258-6125DA1B-558D-402C-B485-217EA4C2FAAA

Q37195258-6A15F0ED-F08A-41E8-8EEA-07B5CAA2672B

Q37195258-9669533F-BD87-411A-823C-B5517C4B518A

Q37195258-A0CB6003-2264-4C68-B016-B9D5EAEDEAA6

Q37195258-A5ED186B-2FEC-42AE-A603-02B9CD548C96

Q37195258-A7FAC38B-97B9-421F-9F8F-75E1A04FACC7

P304

Q37195258-21893C4C-0458-4305-AF4A-261A014548D1

P31

Q37195258-5AAEDB90-4525-454A-AE20-ADC11C97DD77

Q37195258-9e5a83a4-1ebe-4311-8430-0165230da0c3

P356

Q37195258-20A3F9E1-5846-4168-B688-124CA970E090

P433

Q37195258-198F60CF-1CD4-446F-9D7B-26F65D963F9C

P478

Q37195258-1C60894A-7B24-4D15-A8A2-1CCBCC45D03C

P50

Q37195258-C3A912DF-7FFA-400C-B231-B471721C535D

Q37195258-F69D00C4-95C4-4CCA-90A9-743FFF036104

P577

Q37195258-AF6729C3-995D-4189-B1C7-A69F0FC0A620

P5875

Q37195258-A5F0CBF7-F824-444D-A4C6-F153C6401BEE

P698

Q37195258-7E30342B-1312-4065-9914-273C302C01A3

P932

Q37195258-19DA8DFB-55FE-48EB-A46D-9518F0AC3E9C

P356

P1433

P1476

Following up tumor-specific regulatory T cells in cancer patients.

@en

P2093

Clemence Granier

http://www.w3.org/2001/XMLSchema#string

Corinne Tanchot

http://www.w3.org/2001/XMLSchema#string

P2860

Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens.

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.

Regulatory T cells and cancer.

HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients

Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance.

Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma.

Differences in tumor regulatory T-cell localization and activation status impact patient outcome.

VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer.

The T-cell receptor repertoire of tumor-infiltrating regulatory T lymphocytes is skewed toward public sequences.

P304

e25444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.25444

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Laurence Zitvogel

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275029687

http://www.w3.org/2001/XMLSchema#string

P698

24073383

http://www.w3.org/2001/XMLSchema#string

P932

3782156

http://www.w3.org/2001/XMLSchema#string